|
|
Volumn 255, Issue 9, 2008, Pages 1436-1438
|
|
Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity
a
a
a
a
a,b,c
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA1A INTERFERON;
METHYLPREDNISOLONE;
MITOXANTRONE;
NATALIZUMAB;
RITUXIMAB;
ADULT;
CASE REPORT;
CEREBELLAR ATAXIA;
CEREBROSPINAL FLUID;
DISEASE ACTIVITY;
DISEASE DURATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SUBSTITUTION;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
EXPANDED DISABILITY STATUS SCALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
MALE;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RECURRENT DISEASE;
TREATMENT DURATION;
ADOLESCENT;
ANTIBODIES, MONOCLONAL;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
TREATMENT OUTCOME;
|
|
EID: 55149110100
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-0956-x Document Type: Letter |
|
Times cited : (14)
|
|
References (13)
|
